Support Person Intervention to Promote a Smoking Helpline Among Under

Status Completed

Clinical Trial Summary

This pilot study is being done to adapt an effective 1 session phone coaching intervention for nonsmoking support persons to a low income population. This study will also pilot new intervention components including text messaging and health incentives. The goal of the intervention is for support persons to prompt their smoker to use quitline services. To see if these methods are effective, smokers in this study will be asked to complete assessments about their quit attempts and smoking status. The study will also evaluate if the smokers use quitline services or not. The preliminary findings will be used to provide data for an R01 NIH grant submission.

Clinical Trial Description

This is a proposal to conduct a pilot study to adapt an effective 1 session phone coaching intervention for nonsmoking support persons to a low income population. The study will also pilot new intervention components including text messaging and health incentives. The goal of the intervention is for support persons to prompt their smoker to use quitline services. The study will also build on prior work by enrolling smokers for assessments of quit attempts and smoking abstinence. The study uses a non-randomized, single group design. Thirty nonsmoker-smoker dyads will be enrolled in three waves of 10 each. The nonsmokers will receive different intervention components depending on the time of their enrollment. Nonsmokers will complete assessments at baseline and at 1 month follow-up. Smokers will be enrolled for assessments only at baseline and 3 month follow-up. The vendor for the Minnesota state quitline, Alere Wellbeing Inc. (a sole subsidiary of Optum) will track if smokers use quitline services over 3 months of follow-up. The aims of this pilot study are to: (1) Assess the feasibility of enrolling low income, racially diverse nonsmoker-smoker dyads; (2) Adapt and refine the support person intervention components to a low income population with feedback from the nonsmoker participants; and (3) Assess the feasibility of obtaining assessments from the smokers on quit attempts and smoking abstinence outcomes. The preliminary findings will be used to provide data for an R01 NIH grant submission. ;

Study Design

Related Conditions & MeSH terms

Tobacco Cessation

Clinical Trial Details

NCT number	NCT03096145
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	N/A
Start date	May 1, 2017
Completion date	August 24, 2019

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05415371` - Persistent Poverty Counties Pregnant Women With Medicaid	N/A
Not yet recruiting	`NCT04501016` - A Stepped Care Approach to Treating Tobacco Use in Rural Veterans	Phase 2/Phase 3
Completed	`NCT01651611` - Intervention Study to Increase Smoking Cessation Rates Among Public Housing Residents	N/A
Completed	`NCT01570595` - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV	Phase 1/Phase 2
Completed	`NCT01099384` - Tobacco Cessation Treatment for Alaska Native Youth	Phase 1
Completed	`NCT01164306` - The Impact of a Tobacco Control Intervention in African-American Families	N/A
Recruiting	`NCT04865276` - Adaptation and Evaluation of a Culturally and Gender Relevant Tobacco Cessation Among Women in Brazil: An Integrated mHealth Approach	N/A
Recruiting	`NCT02103868` - Medium Vs Low Intensity Intervention in Tobacco Cessation and Control in Zari Workers	N/A
Completed	`NCT00836199` - NicVAX/Placebo as an Aid for Smoking Cessation	Phase 3
Recruiting	`NCT05552534` - Impact of an Intervention of Screening, Treatment Initiation and Referral to PROmote Smoking CEssation in Emergency Department Patients	N/A
Completed	`NCT01482923` - Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations
Completed	`NCT05764343` - The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases	N/A
Completed	`NCT01312480` - Adolescent Smoking Cessation in Pediatric Primary Care	N/A
Completed	`NCT03377738` - Effectiveness of the Spirometry Test as a Motivational Tool for Quitting Tobacco in Primary Care	N/A
Completed	`NCT05095779` - Incentives for Smoking Cessation in Persistent Poverty Counties	N/A
Completed	`NCT03062709` - A Study of Tobacco Smoke and Children With Respiratory Illnesses	N/A
Completed	`NCT00750503` - Workplace Tobacco Cessation And Oral Cancer Screening Study	Phase 3
Withdrawn	`NCT04340102` - Development of a Scalable Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness	N/A
Completed	`NCT01331226` - Support Person Intervention to Promote a Smoking Helpline	N/A
Completed	`NCT04198688` - Effectiveness of Intensive Smoking Cessation Interventions in Patients With Cancer

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Support Person Intervention to Promote a Smoking Helpline Among Under Resourced Smokers

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms